Sanchita Galgalikar, MBA, BS, will serve as the 2023–2024 Executive Fellow in Health Care Association Leadership. This year-long training program provides a rich, in-depth learning experience for pharmacists interested in health care association leadership or managed care pharmacy.
On March 10, AMCP submitted comments to CMS regarding a Notice of Proposed Rulemaking (NPRM) on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children’s Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges, Merit-Based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals. AMCP's comments address whether CMS should consider policies to require payers to include information about prior authorizations for drugs on the Patient Access API, the Provider Access API, and the Payer-to-Payer API and how information on the APIs might interact with existing prior authorization requirements.
AMCP applauds the introduction of the Access to Prescription Digital Therapeutics Act of 2023 into the Senate and House by a bipartisan group of Senators and Representatives. The bill would authorize coverage of prescription digital therapeutics by Medicare and Medicaid, helping millions of Americans receive innovative care to treat a growing range of conditions and illnesses.
With changing industry trends and new legislation, having robust Real World Evidence (RWE) for your organization is more important than ever. In this sponsored webinar, leaders at the forefront of healthcare discuss their experiences with regulatory submissions and selecting quality data.
On March 6, AMCP submitted a comment letter in response to the Centers for Medicare and Medicaid Services' Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies. AMCP's comments support CMS' proposed Universal Foundation and commitment to advancing health equity, as well as the use of inclusive and gender-affirming approaches to HEDIS measures.
